ARCHIVES

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

HEW Says Patent Delays Temporary

August 25, 1978

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

NCI-Approved Clinical Trials

November 24, 2006

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005